Free Trial
→ Uncle Sam now owns 9.9% of Intel (From Porter & Company) (Ad)tc pixel Free PBMWW Stock Alerts

Psyence Biomedical (PBMWW) Competitors

$0.04 -0.01 (-20.00%)
As of 06/9/2026 03:31 PM Eastern
Compare

PBMWW vs. AIMDW, ALVOW, ARAV, ACABW, and BFRIW

Should you buy Psyence Biomedical stock or one of its competitors? MarketBeat compares Psyence Biomedical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Psyence Biomedical include Ainos (AIMDW), Alvotech (ALVOW), Aravive (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), and Biofrontera (BFRIW). These companies are all part of the "pharmaceutical products" industry.

How does Psyence Biomedical compare to Ainos?

Psyence Biomedical (NASDAQ:PBMWW) and Ainos (NASDAQ:AIMDW) are both pharmaceutical products companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, risk, profitability, dividends, earnings, valuation, institutional ownership and media sentiment.

In the previous week, Ainos had 1 more articles in the media than Psyence Biomedical. MarketBeat recorded 2 mentions for Ainos and 1 mentions for Psyence Biomedical. Psyence Biomedical's average media sentiment score of 1.89 beat Ainos' score of 0.93 indicating that Psyence Biomedical is being referred to more favorably in the media.

Company Overall Sentiment
Psyence Biomedical Very Positive
Ainos Positive

Company Net Margins Return on Equity Return on Assets
Psyence BiomedicalN/A N/A N/A
Ainos N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Psyence BiomedicalN/AN/AN/AN/AN/A
Ainos$18.11KN/AN/AN/AN/A

Summary

Ainos beats Psyence Biomedical on 2 of the 3 factors compared between the two stocks.

How does Psyence Biomedical compare to Alvotech?

Alvotech (NASDAQ:ALVOW) and Psyence Biomedical (NASDAQ:PBMWW) are both pharmaceutical products companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, media sentiment, institutional ownership, analyst recommendations, profitability, valuation, earnings and risk.

In the previous week, Alvotech and Alvotech both had 1 articles in the media. Alvotech's average media sentiment score of 1.89 equaled Psyence Biomedical'saverage media sentiment score.

Company Overall Sentiment
Alvotech Very Positive
Psyence Biomedical Very Positive

Company Net Margins Return on Equity Return on Assets
AlvotechN/A N/A N/A
Psyence Biomedical N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alvotech$586.32MN/AN/AN/AN/A
Psyence BiomedicalN/AN/AN/AN/AN/A

Summary

Alvotech beats Psyence Biomedical on 1 of the 1 factors compared between the two stocks.

How does Psyence Biomedical compare to Aravive?

Psyence Biomedical (NASDAQ:PBMWW) and Aravive (NASDAQ:ARAV) are both pharmaceutical products companies, but which is the better business? We will compare the two companies based on the strength of their valuation, media sentiment, risk, analyst recommendations, profitability, institutional ownership, dividends and earnings.

Company Net Margins Return on Equity Return on Assets
Psyence BiomedicalN/A N/A N/A
Aravive N/A N/A N/A

35.8% of Aravive shares are held by institutional investors. 60.4% of Aravive shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

In the previous week, Psyence Biomedical had 1 more articles in the media than Aravive. MarketBeat recorded 1 mentions for Psyence Biomedical and 0 mentions for Aravive. Psyence Biomedical's average media sentiment score of 1.89 beat Aravive's score of 0.00 indicating that Psyence Biomedical is being referred to more favorably in the media.

Company Overall Sentiment
Psyence Biomedical Very Positive
Aravive Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Psyence BiomedicalN/AN/AN/AN/AN/A
AraviveN/AN/AN/A-$0.90N/A

Summary

Psyence Biomedical and Aravive tied by winning 2 of the 4 factors compared between the two stocks.

How does Psyence Biomedical compare to Atlantic Coastal Acquisition Corp. II?

Psyence Biomedical (NASDAQ:PBMWW) and Atlantic Coastal Acquisition Corp. II (NASDAQ:ACABW) are both pharmaceutical products companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, risk, profitability, media sentiment, dividends, valuation and earnings.

In the previous week, Psyence Biomedical had 1 more articles in the media than Atlantic Coastal Acquisition Corp. II. MarketBeat recorded 1 mentions for Psyence Biomedical and 0 mentions for Atlantic Coastal Acquisition Corp. II. Psyence Biomedical's average media sentiment score of 1.89 beat Atlantic Coastal Acquisition Corp. II's score of 0.00 indicating that Psyence Biomedical is being referred to more favorably in the media.

Company Overall Sentiment
Psyence Biomedical Very Positive
Atlantic Coastal Acquisition Corp. II Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Psyence BiomedicalN/AN/AN/AN/AN/A
Atlantic Coastal Acquisition Corp. IIN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Psyence BiomedicalN/A N/A N/A
Atlantic Coastal Acquisition Corp. II N/A N/A N/A

Summary

Psyence Biomedical beats Atlantic Coastal Acquisition Corp. II on 2 of the 2 factors compared between the two stocks.

How does Psyence Biomedical compare to Biofrontera?

Psyence Biomedical (NASDAQ:PBMWW) and Biofrontera (NASDAQ:BFRIW) are both pharmaceutical products companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, media sentiment, earnings, profitability, valuation, dividends and risk.

Company Net Margins Return on Equity Return on Assets
Psyence BiomedicalN/A N/A N/A
Biofrontera N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Psyence BiomedicalN/AN/AN/AN/AN/A
Biofrontera$43.20MN/AN/AN/AN/A

In the previous week, Psyence Biomedical and Psyence Biomedical both had 1 articles in the media. Psyence Biomedical's average media sentiment score of 1.89 beat Biofrontera's score of 1.87 indicating that Psyence Biomedical is being referred to more favorably in the media.

Company Overall Sentiment
Psyence Biomedical Very Positive
Biofrontera Very Positive

Summary

Psyence Biomedical and Biofrontera tied by winning 1 of the 2 factors compared between the two stocks.

Get Psyence Biomedical News Delivered to You Automatically

Sign up to receive the latest news and ratings for PBMWW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PBMWW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PBMWW vs. The Competition

Export
MetricPsyence BiomedicalPharmaceutical Preparations IndustryManufacturing SectorNASDAQ Exchange
Market CapN/A$958.36M$4.87B$12.06B
Dividend YieldN/A4.84%9.42%5.55%
P/E RatioN/A1.4621.7423.76
Price / SalesN/A127.56173.06105.22
Price / CashN/A20.0643.4056.09
Price / BookN/A7.9028.966.72
Net IncomeN/A-$4.82M$118.48M$337.35M
7 Day PerformanceN/A-1.57%-2.62%-1.21%
1 Month PerformanceN/A3.80%-0.10%1.41%
1 Year PerformanceN/A96.26%12.08%23.64%

Psyence Biomedical Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PBMWW
Psyence Biomedical
N/A$0.04
-20.0%		N/A+123.5%$0.00N/AN/AN/A
AIMDW
Ainos
N/A$0.11
-0.3%		N/A+32.4%$0.00$18.11KN/A40
ALVOW
Alvotech
N/A$0.24
-7.7%		N/A-88.5%$0.00$586.32MN/A4
ARAV
Aravive
N/A$0.04
flat		N/AN/A$0.00N/AN/A20
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.00
+13.6%		N/AN/A$0.00N/AN/A15

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:PBMWW) was last updated on 6/10/2026 by MarketBeat.com Staff.
From Our Partners
He Called NVIDIA at $1.10 – Now He Says, “SELL”
The analyst who called NVIDIA at $1.10 now says sell. According to Alexander Green, Chief Investment Strategis...
The Oxford Club | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Tesla. SolarCity. Twitter. This $4 stock is next.
Elon Musk has a clear pattern: when a supplier becomes mission-critical, he acquires it. He bought SolarCity f...
Behind the Markets | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
No. You’re not imagining it…
Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...
Porter & Company | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
This IPO Could Make SpaceX Look Small (Read before June 16)
A red-hot AI startup just filed to go public - already valued at nearly $1 trillion. Wall Street veteran Marc ...
Chaikin Analytics | Sponsoredtc pixel
Former tech executive gives live demo of Elon Musk’s new 70X AI agent
Former tech executive Jeff Brown called Nvidia in 2016 (up 25,155%), spotted Bitcoin at $240 (up 31,219%), and...
Brownstone Research | Sponsoredtc pixel